US FDA flags four observations at Lupin’s Pune biotech facility

The company said it will address the observations and respond to the FDA within the stipulated timeframe, reaffirming its commitment to current Good Manufacturing Practices (cGMP) quality standards across all its facilities.

Leave a Reply

Your email address will not be published. Required fields are marked *